Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
2 Просмотры
administrator
08/04/23
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Показать больше
Комментарии Facebook
Комментариев нет